Flow Cytometric Immunophenotyping of Peripheral T Cell Neoplasms Using CD3 Gating
暂无分享,去创建一个
T. Takubo | T. Hanafusa | M. Tsuji | S. Hara | T. Yokote | T. Akioka | T. Miyoshi | T. Ikemoto | Hidema Tanaka
[1] E. Reinherz,et al. Evidence for the T3-associated 90K heterodimer as the T-cell antigen receptor , 1983, Nature.
[2] B. Nathwani,et al. Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin's Lymphoma Classification Project. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.
[3] I. Lorand-Metze,et al. Adult T-cell leukemia (ATL) with an unusual immunophenotype and a high cellular proliferation rate. , 1996, Leukemia & lymphoma.
[4] T. Hanafusa,et al. Flow cytometric immunophenotyping of adult T-cell leukemia/lymphoma using CD3 gating. , 2005, American journal of clinical pathology.
[5] T. Barbui,et al. Long-term follow-up of patients with peripheral T-cell lymphomas treated up-front with high-dose chemotherapy followed by autologous stem cell transplantation , 2006, Leukemia.
[6] L. Ginaldi,et al. Differential expression of CD3 and CD7 in T‐cell malignancies: a quantitative study by flow cytometry , 1996, British journal of haematology.
[7] K. Kishi,et al. Myeloablative allogeneic hematopoietic stem cell transplantation for non-Hodgkin lymphoma: a nationwide survey in Japan. , 2006, Blood.
[8] Nicola Pimpinelli,et al. WHO-EORTC classification for cutaneous lymphomas. , 2005, Blood.
[9] P. Gaulard,et al. Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphomas. Groupe d'Etudes des Lymphomes de l'Adulte (GELA). , 1998, Blood.
[10] H. Fujiwara,et al. CD8‐positive adult T‐cell leukemia cells with an integrated defective HTLV‐I genome show a paracrine growth to IL‐2 , 1994, American journal of hematology.
[11] E. Reinherz,et al. Discrete stages of human intrathymic differentiation: analysis of normal thymocytes and leukemic lymphoblasts of T-cell lineage. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[12] A. Bagg,et al. Molecular pathology of leukemia and lymphoma. , 1999, American journal of clinical pathology.
[13] H. Rappaport,et al. T‐cell‐rich lymphoproliferative disorders morphologic and immunologic differential diagnoses , 1988, Cancer.
[14] L. Medeiros,et al. Overview of the role of molecular methods in the diagnosis of malignant lymphomas. , 1999, Archives of pathology & laboratory medicine.
[15] A. Hagenbeek,et al. Detection of Minimal Residual Disease in Acute Leukemia by Flow Cytometry a , 1986, Annals of the New York Academy of Sciences.
[16] R. Warnke,et al. Morphologic and immunologic characterization of 50 peripheral T-cell lymphomas. , 1985, The American journal of pathology.
[17] H. Müller-Hermelink,et al. Nodal peripheral T-cell lymphomas and, in particular, their lymphoepithelioid (Lennert’s) variant are often derived from CD8+ cytotoxic T-cells , 2004, Virchows Archiv.
[18] Terry L. Smith,et al. Prognostic factors and treatment of patients with T‐cell non‐Hodgkin lymphoma , 2005, Cancer.
[19] C. Civin,et al. Flow cytometric analysis of human bone marrow. IV. Differential quantitative expression of T-200 common leukocyte antigen during normal hemopoiesis. , 1988, Journal of immunology.
[20] Y. Yamashita,et al. Perforin and granzyme expression in cytotoxic T-cell lymphomas. , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[21] F. Behm,et al. Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia. , 2000, Blood.